QBFM
EBS icon

QS Batterymarch Financial Management’s Emergent Biosolutions EBS Stock Holding History

QS Batterymarch Financial Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-8,300
Closed -$210K – 934
2014
Q1 		$210K Hold
8,300
– – ﹤0.01% 879
2013
Q4 		$191K Hold
8,300
– – ﹤0.01% 895
2013
Q3 		$159K Sell
8,300
-3,000
-27% -$53.6K ﹤0.01% 910
2013
Q2 		$163K Buy
+11,300
New +$164K ﹤0.01% 910

Other funds holding EBS

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

QS Batterymarch Financial Management's EBS Position: Q2 2014 in Review

QS Batterymarch Financial Management sold out of Emergent Biosolutions (EBS) in Q2 2014, closing a stake of 8,300 shares — an estimated $210K sold.

QS Batterymarch Financial Management first reported a position in EBS in Q2 2013 and held it in 4 quarters. The position peaked at $210K in Q1 2014. 160 funds tracked by Wall St. Rank hold EBS as of Q2 2014.

  • QS Batterymarch Financial Management reported no remaining Emergent Biosolutions position as of Q2 2014 after selling out during the quarter.
  • QS Batterymarch Financial Management sold 8,300 Emergent Biosolutions shares in Q2 2014, an estimated $210K.
  • QS Batterymarch Financial Management first reported a position in Emergent Biosolutions in Q2 2013 and held it in 4 quarters.
  • QS Batterymarch Financial Management's Emergent Biosolutions position peaked at $210K in Q1 2014.
  • 160 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q2 2014, filed 14 Aug 2014.